Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/formoterol Turbuhaler vs terbutaline nebulization as reliever therapy in children with moderate asthma exacerbation in the emergency room
2020-001713-20Phase 3Terminated
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide + formoterol in asthma (2 arms), sponsored by Centre Hospitalier Intercommunal de Créteil. Primary endpoint: Treatment success based on pulmonary score. Started Sep 2020; status: terminated.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2020-001713-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001713-20.